667 related articles for article (PubMed ID: 9527138)
1. Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.
Andreasen N; Vanmechelen E; Van de Voorde A; Davidsson P; Hesse C; Tarvonen S; Räihä I; Sourander L; Winblad B; Blennow K
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):298-305. PubMed ID: 9527138
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.
Andreasen N; Hesse C; Davidsson P; Minthon L; Wallin A; Winblad B; Vanderstichele H; Vanmechelen E; Blennow K
Arch Neurol; 1999 Jun; 56(6):673-80. PubMed ID: 10369305
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.
Skoog I; Vanmechelen E; Andreasson LA; Palmertz B; Davidsson P; Hesse C; Blennow K
Neurodegeneration; 1995 Dec; 4(4):433-42. PubMed ID: 8846237
[TBL] [Abstract][Full Text] [Related]
4. No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.
Arai H; Satoh-Nakagawa T; Higuchi M; Morikawa Y; Miura M; Kawakami H; Seki H; Takase S; Sasaki H
Neurosci Lett; 1998 Nov; 256(3):174-6. PubMed ID: 9855368
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.
Andreasen N; Minthon L; Clarberg A; Davidsson P; Gottfries J; Vanmechelen E; Vanderstichele H; Winblad B; Blennow K
Neurology; 1999 Oct; 53(7):1488-94. PubMed ID: 10534256
[TBL] [Abstract][Full Text] [Related]
7. Tau protein in cerebrospinal fluid from semantic dementia patients.
Andersen C; Froelich Fabre S; Ostberg P; Lannfelt L; Wahlund L
Neurosci Lett; 2000 Nov; 294(3):155-8. PubMed ID: 11072138
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease.
Arai H; Higuchi S; Sasaki H
Gerontology; 1997; 43 Suppl 1():2-10. PubMed ID: 9187933
[TBL] [Abstract][Full Text] [Related]
9. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.
Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A
Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945
[TBL] [Abstract][Full Text] [Related]
10. Total tau in cerebrospinal fluid differentiates Alzheimer's disease from vascular dementia.
Leszek J; Małyszczak K; Janicka B; Kiejna A; Wiak A
Med Sci Monit; 2003 Nov; 9(11):CR484-8. PubMed ID: 14586274
[TBL] [Abstract][Full Text] [Related]
11. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
Engelborghs S
Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
[TBL] [Abstract][Full Text] [Related]
12. The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia.
Engelborghs S; Le Bastard N
J Neurol Sci; 2012 Nov; 322(1-2):197-9. PubMed ID: 22947896
[TBL] [Abstract][Full Text] [Related]
13. Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.
Molina L; Touchon J; Herpé M; Lefranc D; Duplan L; Cristol JP; Sabatier R; Vermersch P; Pau B; Mourton-Gilles C
Neuroreport; 1999 Nov; 10(17):3491-5. PubMed ID: 10619631
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease.
Kanai M; Shizuka M; Urakami K; Matsubara E; Harigaya Y; Okamoto K; Shoji M
Neurosci Lett; 1999 May; 267(1):65-8. PubMed ID: 10400250
[TBL] [Abstract][Full Text] [Related]
15. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
[TBL] [Abstract][Full Text] [Related]
16. Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment.
Hampel H; Teipel SJ; Fuchsberger T; Andreasen N; Wiltfang J; Otto M; Shen Y; Dodel R; Du Y; Farlow M; Möller HJ; Blennow K; Buerger K
Mol Psychiatry; 2004 Jul; 9(7):705-10. PubMed ID: 14699432
[TBL] [Abstract][Full Text] [Related]
17. Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.
Sjögren M; Blomberg M; Jonsson M; Wahlund LO; Edman A; Lind K; Rosengren L; Blennow K; Wallin A
J Neurosci Res; 2001 Nov; 66(3):510-6. PubMed ID: 11746370
[TBL] [Abstract][Full Text] [Related]
18. Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients.
Knapskog AB; Eldholm RS; Braekhus A; Engedal K; Saltvedt I
BMC Geriatr; 2017 Sep; 17(1):210. PubMed ID: 28893185
[TBL] [Abstract][Full Text] [Related]
19. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
20. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
